Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
TEM-158 (CMT-9), a New Member of the CMT-Type Extended-Spectrum {beta}-Lactamases
Antimicrobial Agents and Chemotherapy, 10/24/07
Robin, F., et al. - TEM-158 was found to include the substitutions previously observed for TEM-12 and TEM-35. This enzyme presented hydrolytic activity against ceftazidime and a high level of resistance against clavulanate, which can alter its detection. Its discovery highlights the need for accurate detection methods
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Multi-potent Neurotrophin Antagonist Targets Brain-Derived Neurotrophic Factor and Nerve Growth Factor
Journal of Pharmacology and Experimental Therapeutics, 12/04/09
Age-Related Increase in the Frequency of CD4+ T Cells That Produce Interferon-gamma in Response to Staphylococcal Enterotoxin B during Childhood
The Journal of Infectious Diseases, 12/04/09
Article Search
Sponsor


See Latest Articles


